Aridis Pharmaceuticals Inc. - stock earnings
ARDS Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 27, 2024, midnight | - / -0.0200000000 | - | - / 300000 | - |
ARDS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -83000 USD | 417000 USD |
| 2023Q2 | 12.1 million USD | 19.6 million USD |
| 2023Q1 | -5.4 million USD | ? USD |
| 2022Q4 | -6.4 million USD | ? USD |
| 2022Q3 | -9.1 million USD | 399000 USD |
| 2022Q2 | -8.2 million USD | 292000 USD |
| 2022Q1 | -10.2 million USD | 570000 USD |
| 2021Q4 | -10.2 million USD | 570000 USD |
| 2021Q3 | -21.0 million USD | 98000 USD |
| 2021Q2 | -5.5 million USD | 33000 USD |
| 2021Q1 | -6.9 million USD | 7000 USD |
| 2020Q4 | -5.8 million USD | ? USD |
| 2020Q3 | -5.8 million USD | ? USD |
| 2020Q2 | -4.2 million USD | 1.0 million USD |
| 2020Q1 | -5.6 million USD | -1.0 million USD |
| 2019Q4 | -5.6 million USD | ? USD |
| 2019Q3 | -7.6 million USD | ? USD |
| 2019Q2 | -8.4 million USD | ? USD |
| 2019Q1 | -8.1 million USD | 1.0 million USD |
| 2018Q4 | -5.4 million USD | 1.4 million USD |
| 2018Q3 | -7.9 million USD | 1.0 million USD |
| 2018Q2 | -1.4 million USD | 22000 USD |
| 2018Q1 | -7.3 million USD | 322000 USD |
| 2017Q4 | -4.9 million USD | 860000 USD |
| 2017Q3 | -5.4 million USD | 22000 USD |
| 2017Q2 | -6.1 million USD | 22000 USD |
| 2017Q1 | -8.2 million USD | 22000 USD |
| 2016Q4 | -8.4 million USD | 2.3 million USD |
ARDS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -30.7 million USD | 19.3 million USD |
| 2021 | -42.3 million USD | 1.5 million USD |
| 2020 | -22.3 million USD | 1.0 million USD |
| 2019 | -29.0 million USD | 1.0 million USD |
| 2018 | -22.1 million USD | 2.8 million USD |
| 2017 | -24.7 million USD | 860000 USD |
| 2016 | -8.4 million USD | 2.3 million USD |
| 2015 | -8.2 million USD | 2.9 million USD |
ARDS
Price: $0.06
52 week price:
Earnings Per Share: -0.16 USD
P/E Ratio: -0.45
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 543871
Market Capitalization: 3.2 million